US lawmakers again propose diagnostics reform bill

US House lawmakers have re-introduced a bill that would give the Food and Drug Administration (FDA) explicit authority to regulate certain laboratory-developed tests (LDT). The agency has long sought to regulate such tests that are currently overseen by the Centers for Medicare and Medicaid Services (CMS) under the Clinical Laboratory Improvement Amendments (CLIA).